MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis (MSNEUROPLAST)

Cognitive Decline Prognosis in Multiple Sclerosis: Effectiveness of a Computerized Cognitive Training Treatment on Cortical Reorganization

This clinical study aims to identify MS related beneficial plasticity and by contrast maladaptive reorganization in combination with elements of daily functional status as a response to a cognitive training program

Study Overview

• Status: Recruiting
• Conditions: Multiple Sclerosis; Cognitive Decline
• Intervention / Treatment: Other: Cognitive Training; Device: Monitoring of daily activity

Detailed Description

Cognitive decline is a debilitating and widespread comorbidity of Multiple Sclerosis (MS) affecting up to 65 percent of patients with MS (PwMS). Cognitive changes can be the only behavioral index of MS activity. But how accurately and timely can these be captured? The existing clinical tools are subjective and do not have the dynamic of prognosis. It remains uncertain how much change in cognitive status is required to translate into a meaningful clinical outcome and how long it may subsequently take to become apparent. Moving towards a holistic approach, MS-NEUROPLAST aims to further expand previously-published prognostic marker candidates and previous work of the applicant and the members of the research team and employ a group of methodologies for interventions and applications which will quantify via real-world assessment the MS-related cognitive changes in order to characterize not only decline but given the right dosage of stimulation improvement as well.

MS-NEUROPLAST has three main objectives:

(i) Utilize state of-the-art neuroimaging and network science measures to more thoroughly understand neural indices of cognitive impairment in PwMS.

(ii) Evaluate the efficacy for treating MS-associated cognitive deficits using a computerized cognitive training treatment by determining the differences, between subjects treated with cognitive training and controls, on network science measures indexing network efficiency or collapse and on the performance of a battery of neuropsychological tests that are frequently impaired in MS.

(iii) Investigate the dissociation of the cortical mechanisms related to training-induced plasticity and maladaptive reorganization (namely separate good from bad), by taking into account the homeostatic capacity of the human organism as a whole and thus examining whether the correlation of the neurophysiological and cognitive indices with longitudinal digital biomarkers of daily functional status can capture the underlying pathology.

MS-NEUROPLAST stages for PwMS

1. Provide signed informed consent to participate in the study after being informed by the principal investigator.
2. Neurological evaluation and decision on whether the inclusion criteria are met.

3. The participants will visit the Medical Physics & Digital Innovation Lab at AUTH, where:

   A. They will undergo a neuropsychological and somatometric assessment

   B. Then, they will undergo an electroencephalogram (EEG) measurement which includes the following:

   • Placement of the EEG cap holding the electrodes on the head to record the electrical activity of the brain. The cap will be soaked with potassium chloride solution to maintain the electrodes' resistance at desired levels
   • Wear over ear headphones
   • Recording EEG activity at rest for 15 minutes with eyes closed
   • View and listen to a series of simple images and sounds in video format and parallel recording of EEG evoked potentials using a complex eccentric (oddball) protocol combining multisensory audiovisual mismatches with unisensory acoustic and visual deviancies. Concurrently to the EEG measurements the subjects will respond behaviourally via button presses to an audiovisual congruency task on which they have to evaluate whether the images presented correspond to the tones they hear based on the rule: "the higher the pitch of the tone the higher the position of the circle". The recording will be performed 4 times, will include 32 sequences from each category audiovisual congruent, audiovisual incongruent, auditory deviant and visual deviant) resulting in 128 measurements from each condition for each participant. The measurement will take about 45 minutes.

   C. Familiarization with using a personal computer or a tablet, and demonstration of both the BrainHQ environment for cognitive training and the wearable and ambient devices.

4. Use of a set of smart sensors to collect biomarkers (steps, calories, sleep duration, heart rate, oxygen saturation) of daily activities for a period of up to 1 month (at least 2 weeks) before the onset of cognitive training. This will be followed by cognitive training through BrainHQ exercises. The training should be performed with a frequency of at least 3 times a week, for about 60 minutes (30 minutes of pure practice), lasting up to 12 weeks. Adherence will be recorded by the BrainHQ application and any deviations from the schedule will be followed by communication via the telephone or in person aimed at mobilizing and re engaging participants. During cognitive training, the recording of biomarkers of daily activities will continue.
5. At the end of the training, stages 3A and 3B will be repeated.

MS-NEUROPLAST stages for Healthy Controls

1. Provide signed informed consent to participate in the study after being informed by the principal investigator
2. The participants will visit the Medical Physics & Digital Innovation Lab at AUTH, where:

A. They will undergo a neuropsychological and somatometric assessment

B. Then, they will undergo an electroencephalogram (EEG) measurement which includes the following:

• Placement of the EEG cap holding the electrodes on the head to record the electrical activity of the brain. The cap will be soaked with potassium chloride solution to maintain the electrodes' resistance at desired levels
• Wear over ear headphones
• Recording EEG activity at rest for 15 minutes with eyes closed
• View and listen to a series of simple images and sounds in video format and parallel recording of EEG evoked potentials using a complex eccentric (oddball) protocol combining multisensory audiovisual mismatches with unisensory acoustic and visual deviancies. Concurrently to the EEG measurements the subjects will respond behaviourally via button presses to an audiovisual congruency task on which they have to evaluate whether the images presented correspond to the tones they hear based on the rule: "the higher the pitch of the tone the higher the position of the circle". The recording will be performed 4 times, will include 32 sequences from each category audiovisual congruent, audiovisual incongruent, auditory deviant and visual deviant) resulting in 128 measurements from each condition for each participant. The measurement will take about 45 minutes.

• Study Type: Interventional
• Enrollment (Estimated): 180
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Charis Styliadis, PhD; Phone Number: +30 6942618582; Email: styliadis@hotmail.com
• Study Contact Backup: Name: Panagiotis D Bamidis, PhD; Email: bamidis@auth.gr

Study Locations

• Greece
  • Central Macedonia
    • Thessaloníki, Central Macedonia, Greece, 54124
      • Recruiting
      • Laboratory of Medical Physics and Digital Innovation, AUTH
      • Contact: Charis Styliadis, PhD; Phone Number: 6942618582; Email: styliadis@hotmail.com
      • Contact: Panagiotis D Bamidis, PhD
      • Contact: Nikolaos Grigoriadis, PhD
      • Contact: Vahe Poghosyan, PhD
      • Contact: Ioannis Nikolaidis, PhD
      • Contact: Antonis Billis, PhD
      • Contact: Vasiliki Zilidou, PhD
      • Contact: Panagiotis Kartsidis, MSc
      • Contact: Alexandra Anagnostopoulou, MSc

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 55 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria for people with MS:

• Male/female patients aged 18 to 65 years at screening
• Diagnosis of MS according to the 2017 Revised McDonald criteria
• Disability status at screening with an EDSS score of 0 to 6.5
• Relapsing MS and progressive MS as defined by Lublin
• Neurologically stable within 1 month prior to screening
• Patients receiving the same Disease Modifying Treatment (DMT) for at least 6 months

Exclusion Criteria for people with MS:

• Patients suspected of not being able or willing to cooperate or comply with study protocol requirements
• Patients meeting criteria for other demyelinating diseases of the CNS
• Patients with active chronic disease (or stable but treated with immune therapy) of the immune system other than MS
• Patients with any other significant CNS disease or serious psychiatric disorder which can interfere with the patient's ability to cooperate or comply with the study procedure
• Patients unable or unwilling to undergo MRI scans and EEG

Inclusion Criteria for Healthy Controls:

• Normal hearing and normal or corrected-to-normal vision

Exclusion Criteria for Healthy Controls:

• Any diagnosed neurological, mental, developmental, or psychiatric disorder
• Unrecovered neurological disorders (i.e., stroke, traumatic brain injury)
• Unstable medication within the last 3 months
• Intake of central nervous drugs (e.g., antidepressants)
• Severe physical disorder
• Concurrent participation in another relevant study
• Patients unable or unwilling to undergo EEG measurements

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: HC; Healthy adults serving as passive controls.; 2 types of high-density electroencephalographic recordingsat rest with eyes closed (15 minutes)event potentials via a multisensory oddball paradigm (45 minutes); Neuropsychological assessmentMini Mental Status Examination (MMSE)Greek Verbal Learning Test (GVLT)Brief Visuospatial Memory Test (BVMT)Symbol Digit Modalities Test (SDMT); Somatometric assessmentTimed 25-Foot Walk (T25-FW)3m backwards walk testHole Peg Test (9-HPT)Handgrip Strength TestSingle Leg Stance (SLS)Four Square Step Test (FSST)
Experimental: PwMS-CCT; Adult individuals with Multiple Sclerosis will follow a cognitive training intervention.; Neurological assessmentHistory of Multiple SclerosisExpanded Disability Status Scale (EDSS); 2 types of high-density electroencephalographic recordingsat rest with eyes closed (15 minutes)event potentials via a multisensory oddball paradigm (45 minutes); Neuropsychological assessmentMMSECDTGVLTBVMTSDMTVerbal Fluency: Phonemic [ Chi-Sigma-Alpha] and Semantic [Animals-Fruits-Objects]Digit Span (For-Back-Seq)_WAIS-4GRSNSTGATDASS21MSIS-29CRIqMFISEQ-5D-5LBDI-II; Somatometric assessmentTimed 25-Foot Walk (T25-FW)3m backwards walk testHole Peg Test (9-HPT)Handgrip Strength TestSingle Leg Stance (SLS)Four Square Step Test (FSST); BrainHQ training; Monitoring of daily activity	Other: Cognitive Training; The cognitive training treatment is a Greek adaptation of BrainHQ developed by Posit Science Corporation. The intervention will target speed, attention, working memory, and executive function through the visual and auditory domains via a set of 15 exercises. Each daily training session consists of four exercises chosen from an active set of six. Participants will be instructed to train for one hour per day, three days per week, over 12 weeks via a tablet. Each subject will receive at least 29 sessions of computerized cognitive training.; Device: Monitoring of daily activity; Monitoring of daily activity via Fitbit Charge 4 smartwatch.
Active Comparator: PwMS-CON; Adult individuals with Multiple Sclerosis serving as active controls.; Neurological assessmentHistory of Multiple SclerosisExpanded Disability Status Scale (EDSS); 2 types of high-density electroencephalographic recordingsat rest with eyes closed (15 minutes)event potentials via a multisensory oddball paradigm (45 minutes); Neuropsychological assessmentMini Mental Status Examination (MMSE)Clock Drawing Test (CDT)Greek Verbal Learning Test (GVLT)Brief Visuospatial Memory Test (BVMT)Symbol Digit Modalities Test (SDMT)Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] and Semantic [Animals-Fruits-Objects]Digit Span (For-Back-Seq)_WAIS-4GRStroop Neuropsychological Test (SNST)The Greek Accentuation Test (GAT)DASS-21MSIS-29CRIqMFISEQ-5D-5LBDI-II; Somatometric assessmentT25-FW3m backwards walk test9-HPTHandgrip Strength TestSLSFSST; Monitoring of dailty activity	Device: Monitoring of daily activity; Monitoring of daily activity via Fitbit Charge 4 smartwatch.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in current density strength of the cortical activity as measured via EEG	Changes in cortical activity strength caused via the training. Change is defined as statistical significance in the t-test comparison of the current density strength as reconstructed via Low Resolution Electromagnetic Tomography (LORETA) algorithm on the basis of high-density EEG recordings, before compared to after the training.	3 months
Change in cortical connectivity as measured via EEG	Changes in cortical connectivity caused via the training. Change is defined as statistical significance in the t-test comparison of Phase Transfer Entropy estimated from the cortical activity, as reconstructed via LORETA algorithm on the basis of high density EEG recordings, before compared to after the training.	3 months
Changes in the graph theory indexes as measured via EEG	Changes in the global and local graph theoretical indices of the brain networks caused via the training. Change is defined as statistical significance in the t-test comparison of the graph theory indices before compared to after the training.	3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in audiovisual integration functionality	Change of accuracy in the behavioral measurement testing audiovisual integration. Change is defined as statistical significance in the t-test comparison before compared to after the training. A lower score denotes a decline.	3 months
Change in Mini Mental Status Examination (MMSE)	The Mini-Mental State Exam (MMSE) is a test of cognitive function. It includes tests of orientation, attention, memory, language, and visual-spatial skills. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 100 (max). A lower score denotes a decline.	3 months
Change in Clock Drawing Test (CDT)	The Clock-Drawing Test (CDT) is a simple and effective cognitive test used to assess executive function and visual-spatial function. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 15 (max). A lower score denotes a decline.	3 months
Change in Brief Visuospatial Memory Test (BVMT)	The Brief Visuospatial Memory Test (BVMT) measures visuospatial memory. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 36 (max). A lower score denotes a decline.	3 months
Change in Symbol Digit Modalities Test (SDMT)	The Symbol Digit Modalities Test (SDMT) is a screening instrument to assess cognitive function and especially processing speed. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 110 (max). Scoring involves summing the number of correct substitutions within the 90-second interval. A lower score denotes a decline.	3 months
Change in Verbal Fluency: Phonemic [ Chi-Sigma-Alpha]	Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] is a test of verbal fluency to evaluate the ability to retrieve specific information within restricted search parameters. It can be used as an efficient screening instrument for general verbal functioning. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 to as many as many different words as possible generated beginning with each of the following three Greek letters: X (Chi), S (Sigma), and A (Alpha) within 60 seconds. A lower score denotes a decline.	3 months
Change in Verbal Fluency: Semantic [Animals-Fruits-Objects]	Verbal Fluency: Semantic [Animals-Fruits-Objects] is a test of verbal fluency to evaluate the ability to retrieve specific information within restricted search parameters. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 to as many as many unique words as possible generated within a semantic category (Animals, Fruits, Objects) in 60 seconds. A lower score denotes a decline.	3 months
Change in Digit Span (For-Back-Seq) _WAIS-4GR	Digit Span (For-Back-Seq) _WAIS-4GR is a tool to measure one's verbal short-term and working memory. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 48 (max). A lower score denotes a decline.	3 months
Change in Stroop Neuropsychological Test (SNST)	Stroop Neuropsychological Test (SNST) provides a brief screening for brain damage, dysfunction of selective attention, and cognitive flexibility. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to the sum of correct answers within 2 minutes. A lower score denotes a decline.	3 months
Change in Greek Accentuation Test (GAT)	The Greek Accentuation Test (GAT) is a test of premorbid intellectual functioning. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 50 (max). A lower score denotes a decline.	3 months
Change in Depression Anxiety Stress Scale (DASS-21)	Depression Anxiety Stress Scale (DASS-21) is a self-report scale designed to measure the negative emotional states of depression, anxiety, and stress. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 63 (max). A lower score denotes an amelioration or absence of symptoms.	3 months
Change in Multiple Sclerosis Impact Scale (MSIS-29)	Multiple sclerosis Impact Scale (MSIS-29) measures coordination, fatigue, flexibility, muscle performance, muscle tone/spasticity, balance/falls, reach and grasp, self-care, health and wellness, leisure, quality of life, role function, social function, and work. A 29-item, self-report questionnaire designed to measure the physical and psychological impact of MS. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 29 (min) to 116 (max). A lower score denotes an amelioration or absence of symptoms.	3 months
Change in the Cognitive Reserve Questionnaire (CRIq)	The Cognitive Reserve Questionnaire (CRIq) is an instrument for measuring cognitive reserve. Change is defined as statistical significance in the comparison between before and after the training. The questionnaire is divided into 3 sections: CRI-Education, CRI-WorkingActivity, CRI-LeisureTime. The CRIq score falls into 1 of 5 ordered levels: low (less than 70); medium-low (70-84); medium (85-114); medium-high (115-130); and high (more than 130). A lower score means a lower cognitive reserve.	3 months
Change in Modified Fatigue Impact Scale (MFIS)	The Modified Fatigue Impact Scale (MFIS) is a structured, self-report questionnaire that concerns how fatigue impacts their lives. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 84 (max). A lower score denotes an amelioration or absence of symptoms.	3 months
Change in EQ-5D-5L	The EQ-5D-5L is a self-assessed, health-related, quality-of-life questionnaire. The scale measures the quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Change is defined as statistical significance in the comparison between before and after the training. A lower score denotes an amelioration or absence of symptoms.	3 months
Change in EQ-5D-5L -EQ-VAS	Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0% (min) to 100% (max). The lower the score, the worse the perception of health.	3 months
Change in Beck Depression Inventory-Fast Screen (BDI-FS)	Beck Depression Inventory-Fast Screen (BDI-FS) is a 21-question self-report inventory for measuring the severity of depression. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 21 (max). A lower score denotes an amelioration or absence of symptoms.	3 months
Change in Timed 25-Foot Walk (T25-FW)	The Timed 25-Foot Walk (T25-FW) assesses walking speed and general walking ability on a ~8m (7.62m) corridor. The T25FW score is calculated by averaging the two tests performed (in seconds). Time limit per trial: 3 minutes (180 seconds). Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.	3 months
Change in 3 m backwards walk test	The 3 m backwards walk test assesses backward walking which is more sensitive to detecting changes in mobility and balance than walking forward. The score records the time (in seconds) per trial. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.	3 months
Change in Hole Peg Test (9-HPT)	The Hole Peg Test (9-HPT) is a brief, standardized, quantitative test that assesses upper extremity functionality, looking at how well the patient can use both their primary and non-primary hand to perform a specific task. Time limit per trial: 5 minutes (300 seconds). Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.	3 months
Change in Four Square Step Test (FSST)	The Four Square Step Test (FSST) assesses dynamic stability and the subject's ability to step over low objects forward, sideways, and backward. The aim is to step as fast as possible into each square with both feet in the following sequence: Square 2, 3, 4, 1, 4, 3, 2, 1 (clockwise to counterclockwise). The best time (in seconds) of two FSST is the score. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.	3 months
Change in Single Leg Stance Test (SLS)	The Single Leg Stance Test (SLS): assesses static postural and balance control and is a valuable clinical tool for monitoring neurological and musculoskeletal status as well as for managing fall risk. It is tested on both legs. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.	3 months
Change in the Handgrip Strength Test	The Handgrip Strength Test assesses endurance to the maximum strength of the upper limbs. Grip strength is typically measured in kilograms by squeezing a type of muscle strength testing equipment, known as a dynamometer in each hand. The average healthy grip strength for men is a squeeze of about 33kg while women typically measure around 20kg. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of squeeze denotes improvement.	3 months

Collaborators and Investigators

• Sponsor: Aristotle University Of Thessaloniki
• Collaborators: King Fahad Medical City
• Investigators: Principal Investigator: Charis Styliadis, PhD, Aristotle University of Thessaloniki

Publications and helpful links

General Publications

• Styliadis C, Kartsidis P, Paraskevopoulos E, Ioannides AA, Bamidis PD. Neuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states. Neural Plast. 2015;2015:172192. doi: 10.1155/2015/172192. Epub 2015 Apr 7.
• Klados MA, Styliadis C, Frantzidis CA, Paraskevopoulos E, Bamidis PD. Beta-Band Functional Connectivity is Reorganized in Mild Cognitive Impairment after Combined Computerized Physical and Cognitive Training. Front Neurosci. 2016 Feb 29;10:55. doi: 10.3389/fnins.2016.00055. eCollection 2016.

Helpful Links

• MS-NEUROPLAST webpage
• MS-NEUROPLAST Facebook page

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2020
• Primary Completion (Estimated): December 31, 2025
• Study Completion (Estimated): December 31, 2025

Study Registration Dates

• First Submitted: March 3, 2021
• First Submitted That Met QC Criteria: March 18, 2021
• First Posted (Actual): March 19, 2021

Study Record Updates

• Last Update Posted (Estimated): November 4, 2024
• Last Update Submitted That Met QC Criteria: October 31, 2024
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Keywords: EEG; Cognitive Training; Adaptive; Plasticity; Network Efficiency; Maladaptive Reorganization
• Additional Relevant MeSH Terms: Nervous System Diseases; Mental Disorders; Pathologic Processes; Autoimmune Diseases; Immune System Diseases; Neurocognitive Disorders; Demyelinating Autoimmune Diseases, CNS; Autoimmune Diseases of the Nervous System; Demyelinating Diseases; Cognition Disorders; Multiple Sclerosis; Sclerosis; Cognitive Dysfunction
• Other Study ID Numbers: 98223

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No